Lactobacillus rhamnosus MY-1 alleviates deoxynivalenol-induced oxidative stress, inflammation, and gut microbiota dysbiosis both in vivo and in vitro
Frontiers in Microbiology · 16.02.2026 · 17
DOI: 10.3389/fmicb.2026.1750402 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 16.02.2026. Verfasst von Yukai Lin und 12 weiteren Autor:innen. Beteiligte Einrichtung: College of Animal Science and Veterinary Medicine, Henan Institute of Science and Technology, Xinxiang, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Introduction
Deoxynivalenol (DON), a prevalent mycotoxin in grains and feed, poses a serious threat to animal health by inducing intestinal dysfunction. While some probiotics are known to mitigate DON toxicity, the multifaceted protective effects of Lactobacillus rhamnosus MY-1—a strain with high DON-degradation capacity and a proven safety profile—require comprehensive evaluation. This study aimed to systematically assess the ability of MY-1 to alleviate DON-induced oxidative stress, inflammation, and gut microbiota dysbiosis, and to elucidate its underlying mechanisms.
Methods
Investigations were conducted in vitro using IPEC-J2 cells and in vivo using a BALB/c mouse model. We examined the effects of MY-1 on cell viability, ultrastructure, oxidative stress markers (MDA, T-AOC), inflammatory cytokines (TNF-α, IL-1α, IL-4), apoptosis-related genes (BAX, Caspase-3, BCL-2), and tight junction protein (ZO-1, Occludin, Claudin-1) expression. Gut microbiota composition was analyzed via alpha (Chao1, Simpson, Shannon) and beta diversity indices.
Results
The MY-1 supernatant restored IPEC-J2 cell viability and ameliorated DON-induced ultrastructural damage. MY-1 alleviated oxidative stress by reducing MDA and enhancing T-AOC, while inhibiting pro-inflammatory cytokines (TNF-α, IL-1α) and promoting the anti-inflammatory cytokine IL-4. In mice, MY-1 mitigated DON-induced growth inhibition and intestinal pathological damage, restored tight junction protein expression, and regulated apoptosis-related genes. Gut microbiota analysis showed that MY-1 reversed DON-induced dysbiosis, restoring alpha diversity and beta diversity structure, and modulated the abundances of dominant genera such as Bacteroides and Dubosiella .
Discussion
This study demonstrates that Lactobacillus rhamnosus MY-1 exerts comprehensive protective effects against DON-induced intestinal toxicity through integrated mechanisms, including direct detoxification, antioxidant and anti-inflammatory activities, and microbiota modulation. These findings underscore the value of MY-1 as a well-characterized probiotic candidate for mitigating mycotoxin effects in animal production.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Animal Science and Veterinary Medicine, Henan Institute of Science and Technology, Xinxiang, China.
- Laboratory of Functional Microbiology and Animal Health, Henan University of Science and Technology, Luoyang, China.
- Luoyang Key Laboratory of Live Carrier Biomaterial and Animal Disease Prevention and Control, Henan University of Science and Technology, Luoyang, China.
- The Key Lab of Animal Disease and Public Health, Henan University of Science and Technology, Luoyang, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Lin, Y., Wang, R., Yao, J., Zhao, H., Yu, Z., Wen, B., Jia, Y., Liao, C., Guo, R., Wang, L., Xia, X., Xu, Y., & Ding, K. (2026). Lactobacillus rhamnosus MY-1 alleviates deoxynivalenol-induced oxidative stress, inflammation, and gut microbiota dysbiosis both in vivo and in vitro. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1750402
Vancouver
Lin Y, Wang R, Yao J, Zhao H, Yu Z, Wen B, et al. Lactobacillus rhamnosus MY-1 alleviates deoxynivalenol-induced oxidative stress, inflammation, and gut microbiota dysbiosis both in vivo and in vitro. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1750402
BibTeX
@article{Lin2026,
author = {Lin, Yukai and Wang, Ruibiao and Yao, Jie and Zhao, Hanqing and Yu, Zuhua and Wen, Bo and Jia, Yanyan and Liao, Chengshui and Guo, Rongxian and Wang, Lei and Xia, Xiaojing and Xu, Yanzhao and Ding, Ke},
title = {Lactobacillus rhamnosus MY-1 alleviates deoxynivalenol-induced oxidative stress, inflammation, and gut microbiota dysbiosis both in vivo and in vitro},
journal = {Frontiers in Microbiology},
year = {2026},
volume = {17},
doi = {10.3389/fmicb.2026.1750402}
}
EUVIMED